Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY - Get Free Report)'s stock price reached a new 52-week low on Tuesday . The company traded as low as $10.00 and last traded at $10.00, with a volume of 118 shares trading hands. The stock had previously closed at $10.3162.
Ambu A/S Trading Down 3.1%
The firm has a 50 day simple moving average of $12.04 and a 200 day simple moving average of $13.56. The company has a current ratio of 2.86, a quick ratio of 1.67 and a debt-to-equity ratio of 0.08. The firm has a market capitalization of $2.35 billion, a PE ratio of 32.26 and a beta of 1.25.
Ambu A/S (OTCMKTS:AMBBY - Get Free Report) last issued its earnings results on Wednesday, February 4th. The company reported $0.07 EPS for the quarter. Ambu A/S had a return on equity of 9.15% and a net margin of 8.86%.The business had revenue of $242.85 million for the quarter.
Ambu A/S Company Profile
(
Get Free Report)
Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company's core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu's offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.
Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ambu A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambu A/S wasn't on the list.
While Ambu A/S currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.